Related Experiment Video
Updated: Mar 22, 2026

Amide Coupling Reaction for the Synthesis of Bispyridine-based Ligands and Their Complexation to Platinum as Dinuclear Anticancer Agents
Published on: May 28, 2014
Pyridine Based Antitumour Compounds Acting at the Colchicine Site
R Álvarez, L Aramburu, P Puebla
1Departamento de Química Farmacéutica, Facultad de Farmacia, Campus Miguel de Unamuno s/n, Universidad de Salamanca, Salamanca, 37007, Spain. pelaez@usal.es.
Pyridines and azines are key scaffolds in developing novel antimitotic agents that target tubulin. This review explores pyridine and azine-containing colchicine site ligands (CSLs) for improved cancer and vascular disruption therapies.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Organic Chemistry
Background:
- Antimitotic agents targeting the colchicine site of tubulin are crucial for cancer and vascular disruption therapies.
- Pyridines and azines are prevalent heterocyclic scaffolds in medicinal chemistry.
- Recent drug discovery efforts focus on incorporating these scaffolds into colchicine site ligands (CSLs) to enhance drug properties.
Purpose of the Study:
- To review and classify pyridine and azine-containing antimitotic compounds.
- To discuss the design principles and structure-activity relationships of these CSLs.
- To analyze successes and failures and outline future research directions.
Main Methods:
- Literature review and classification of CSLs based on chemical structure.
- Analysis of structural modifications involving pyridine and azine moieties.
- Correlation of structural changes with observed biological activity.
Main Results:
- CSLs incorporating pyridine and azine scaffolds demonstrate significant antimitotic activity.
- Structural modifications influence pharmacokinetic and pharmacodynamic profiles.
- Specific examples of successful and less successful CSL designs are presented.
Conclusions:
- Pyridine and azine scaffolds are valuable for developing potent and effective CSLs.
- Understanding structure-activity relationships is key to optimizing CSLs for therapeutic applications.
- Further research into these heterocycles holds promise for novel anticancer and vascular disrupting agents.
More Related Videos
09:00An In Vitro Enzymatic Assay to Measure Transcription Inhibition by GalliumIII and H3 5,10,15-trispentafluorophenylcorroles
Published on: March 18, 2015
08:46Regioselective O-Glycosylation of Nucleosides via the Temporary 2',3'-Diol Protection by a Boronic Ester for the Synthesis of Disaccharide Nucleosides
Published on: July 26, 2018
Related Concept Videos
Drugs that Destabilize Microtubules
Drugs that Stabilize Microtubules
Drugs for Treatment of Ulcerative Colitis in IBD
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Antifungal Agents
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase